Intron Biotechnology Inc. | |
Stock Exchange | Korea Exchange |
EPS |
KRW172 |
Market Cap |
KRW628.61 B |
Shares Outstanding |
15.04 M |
Public Float |
10.66 M |
Address |
Unit 701-704, Joong-Ang Induspia Seongnam-si GY 13202 Korea, Republic Of |
Employees | - |
Website | http://www.intron.co.kr |
Updated | 09/14/2018 |
iNtRON Biotechnology, Inc. engages in the development of super-bacteria treatment, antibiotics alternatives, bio new drug, molecular diagnostics and artificial blood. Its products include anti-bacterial agents, identification kits, research reagents and kits. The company was founded on January 18, 1999 and is headquartered in Seongnam-si, South Korea. |